National Research Corp

National Research Corp. engages in the provision of analytics and insights that facilitate patient, employee, and customer retention. It offers solutions that address specific needs around market insight, experience, transparency, and governance for healthcare providers, payers, and other healthcare organizations. The company was founded by Michael D. Hays in 1981 and is headquartered in Lincoln, NE.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

NRC Health reports mixed Q4 2022 results amidst growth opportunities

NRC Health faced challenges in operating income and tax rates in Q4 2022 but demonstrated strength in core offering growth and client relationships.
The company's focus on humanized healthcare and capital allocation for innovation present opportunities for future growth and competitiveness.
Strategic adjustments post the Canadian location closure and efficient capital expenditure management will be key to overcoming challenges and seizing opportunities.
Overall, NRC Health's performance in Q4 2022 reflects a mix of challenges, strengths, and opportunities that will shape its future trajectory in the healthcare industry.

NRC Health reports Q1 revenue decline, focuses on healthcare humanization

NRC Health faced revenue and operating income declines in Q1 2023, attributed to a location closure and increased marketing expenses.
Despite challenges, the company's recognition as a top workplace and clear capital allocation priorities showcase strengths and strategic focus.
Opportunities lie in leveraging healthcare humanization and patient insights for future growth and exploring new markets for revenue diversification.

National Research Corp reports sales surge amidst revenue decline

NRC's Q2 2023 earnings call highlighted mixed financial performance with strong sales growth but revenue and income declines. The company's strategic focus on the Human Understanding Program and cost alignment presents opportunities for future growth and efficiency.

National Research Corp (NRC) reports mixed Q3 results, eyes growth opportunities

National Research Corp (NRC) navigated Q3 2023 with a focus on revenue growth acceleration and margin expansion. Despite challenges in operating income, the company's strategic initiatives and strong balance sheet position it well for future growth opportunities.

National Research Corp (NRC) reports mixed Q4 results, eyes growth opportunities

National Research Corp (NRC) navigated mixed financial results in Q4 2023, with a focus on strategic realignment to meet client demands and achieve growth. While facing challenges such as revenue decline and profitability pressures, the company remains committed to innovation and long-term sustainability. Future opportunities lie in expanding market reach, launching new products, and enhancing operational efficiency.

National Research Corp (NRC) posts solid Q1 results, eyes tech-driven growth

National Research Corp (NRC) reported solid Q1 2024 performance, focusing on technology-driven healthcare insights and strategic initiatives to drive growth and value creation for investors.
The company's emphasis on innovation, expanding the total addressable market, and enhancing client interactions underscores their commitment to delivering actionable insights and sustainable financial results.
With a strong financial foundation, NRC is well-positioned to navigate challenges, capitalize on opportunities, and drive continued growth through investments in technology, sales, and product development.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

National Research Corp has drifted lower in the last 2 months despite the rally in broad indices. The firm presents with attractive business economics that sees it throw off cash to shareholders without jeopardising long-term growth.

National Research Corp: Economic Earnings, Capital Productivity Standout

Innovative approach and service-leading team set NRC Health apart in exhaustive selection process Innovative approach and service-leading team set NRC Health apart in exhaustive selection process

UCHealth Partners with NRC Health to Improve Healthcare Experiences

LINCOLN, Neb, May 02, 2023 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the first quarter 2023.

National Research Corporation Announces First Quarter 2023 Results

Lincoln, Nebraska, April 18, 2023 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ/:NRC) today announced that it will provide an online web simulcast of its 2023 first quarter earnings conference call on Wednesday, May 3, 2023. The Company's results for the 2023 first quarter will be released after the close of the market on Tuesday, May 2, 2023.

National Research Corporation to Broadcast its 2023 First Quarter Conference Call Live on the Internet

Report details new data, trends, and strategies for pediatric healthcare organizations Report details new data, trends, and strategies for pediatric healthcare organizations

NRC Health reveals 2023 Pediatric Experience Perspective

Compliment Sharing helps organizations deliver patient appreciation directly to frontline care teams Compliment Sharing helps organizations deliver patient appreciation directly to frontline care teams

NRC Health energizes healthcare organizations with digital solution to ease burnout for care teams

MyView enhances care team workflow with contextual patient data for improved outcomes MyView enhances care team workflow with contextual patient data for improved outcomes

NRC Health offers first-of-its-kind patient experience EHR integration

Report details new data, trends, and strategies for healthcare organizations Report details new data, trends, and strategies for healthcare organizations

Keys to delivering humanized care revealed in NRC Health's 2023 Experience Perspective

National Research Corporation (NASDAQ:NRC ) Q4 2022 Earnings Conference Call February 15, 2023 11:00 AM ET Company Participants Kevin Karas - CFO Linda Stacy - VP, Finance Conference Call Participants George D'Angelo - Alpine Peaks Capital Operator Hello, and welcome to the National Research Corporation Fourth Quarter 2022 Earnings Call. My name is Elliot and I'll be coordinating your call today.

National Research Corporation (NRC) Q4 2022 Earnings Call Transcript

LINCOLN, Neb., Feb. 14, 2023 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the fourth quarter and calendar year 2022.

National Research Corporation Announces Fourth Quarter and Calendar Year 2022 Results

Top-ranking reinforces commitment to service and humanized care as industry standard Top-ranking reinforces commitment to service and humanized care as industry standard

NRC Health recognized as Best in KLAS for Patient Experience Improvement

Lincoln, Nebraska, Jan. 30, 2023 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ/:NRC) today announced that it will provide an online web simulcast of its 2022 fourth quarter earnings conference call on Wednesday, February 15, 2023. The Company's results for the 2023 fourth quarter will be released after the close of the market on Tuesday, February 14, 2023.

National Research Corporation to Broadcast its 2022 Fourth Quarter Conference Call Live on the Internet

CoreCard Corp

MarineMax

Kulicke & Soffa Industries

Marcus & Millichap

New York Times

Werner Enterprises

Whether it's at the gas pump or the grocery store, 50 bucks won't get you nearly as far these days as it did a year ago. However, with the major indices down between 9% and 33% in 2022, traders may find their investment dollars going further than they used to.

7 Stocks Under $50 to Buy and Hold Forever

National Research Corporation (NASDAQ:NRC ) Q3 2022 Earnings Conference Call November 3, 2022 10:00 AM ET Company Participants Linda Stacy - VP, Finance Kevin Karas - Chief Financial Officer Conference Call Participants George D'Angelo - Alpine Peaks Capital Operator Hello, and welcome to the National Research Corporation's Third Quarter 2022 Earnings Call. My name is Bailey and I'll be your moderator for today's today.

National Research Corporation (NRC) Q3 2022 Results - Earnings Call Transcript

CEVA

FutureFuel

Mastech Digital

Noah Holdings Ltd.

Omega Flex

Investors may want to target small-cap stocks to buy. Understandably, smaller and therefore less-proven enterprises present higher risks, which is why some folks avoid the sector.

7 Small-Cap Stocks to Buy Before the Market Starts to Soar in 2023

LINCOLN, Neb., Nov. 01, 2022 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the third quarter 2022.

National Research Corporation Announces Third Quarter 2022 Results

Trust in individual healthcare providers depends largely on patients' language preferences

NRC Health Study Finds Trust in Local Hospitals and Health Systems Increased During the Pandemic

Lincoln, Nebraska, Oct. 19, 2022 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ/:NRC) today announced that it will provide an online web simulcast of its 2022 third quarter earnings conference call on Wednesday, November 2, 2022. The Company's results for the 2022 third quarter will be released after the close of the market on Tuesday, November 1, 2022.

National Research Corporation to Broadcast its 2022 Third Quarter Conference Call Live on the Internet

Year-Long, Four-Part Event Series Aims to Accelerate the Participatory Medicine Movement to Foster Deeper Patient-Provider Relationships Year-Long, Four-Part Event Series Aims to Accelerate the Participatory Medicine Movement to Foster Deeper Patient-Provider Relationships

NRC Health Announces Sponsorship of Creative Learning Event Series Hosted by the Society for Participatory Medicine

Investors continue to compress the National Research Corporation share price in continuation with long-term downtrends. The stock has caught a bid of late as the market continues to reward bottom-line fundamentals over top-line growth.

National Research Corp: Market Is Discounting These Key Factors

One of these stocks has even doubled its dividend.

3 High-Yielding Dividend Stocks That Boosted Their Payouts by Over 25% Within the Past Year

Top 100 Hospitals Excelling Across Seven Aspects of Consumer Loyalty Earn National Honors in Fifth-Annual Consumer Loyalty Awards

NRC Health Unveils Winners of 2022 Annual Awards Programs

Supporting Partnership Enables Ongoing Collaboration with Healthcare Organizations Working to Improve Patient Experience Supporting Partnership Enables Ongoing Collaboration with Healthcare Organizations Working to Improve Patient Experience

NRC Health Announces Partnership with The Beryl Institute

National Research Corporation (NASDAQ:NRC ) Q2 2022 Earnings Conference Call August 3, 2022 11:00 AM ET Company Participants Michael Hays - Founder and Chief Executive Officer Kevin Karas - Chief Financial Officer Conference Call Participants John Lewis - Willis Investment Counsel George D'Angelo - Alpine Peaks Capital Operator Hello, everyone, and welcome to the National Research Corporation's Second Quarter 2022 Earnings Call. My name is Charlie and I'll be coordinating the call today.

National Research Corporation's (NRC) CEO Michael Hays on Q2 2022 Results - Earnings Call Transcript

LINCOLN, Neb., Aug. 02, 2022 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the second quarter 2022.

News for National Research Corp Stock (NRC)